Google TrendMATTHEW STONE SR (200+) — Adult victims, suspected shooter ID'd in Erie mass shooting
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Checkpoint Inhibitor Refractor" (30 stories)

Top Headline Story

Checkpoint Inhibitor Refractory Cancer Market Size, Forecast, Demand, 2034
Lead StoryStraits Researchmarkets
3d ago

Checkpoint Inhibitor Refractory Cancer Market Size, Forecast, Demand, 2034

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNVFhzRDhLZkxCcTBQSkFJLTFqNDdRaXFEZ1lCSHRqOGVGVG56MzRWdFhYQ0VQQ0wyR2lIam5pdHZGdWdrMnBFQkVNQVVFckViWlJHU0hpRjEyV2NtWk8zQS1JRW1XcXh6NmxRQzBRSnJ6WEF5OVlxUE9RakVxRjZBdEFBTm91aVE?oc=5" target="_blank">Checkpoint Inhibitor Refractory Cancer Market Size, Forecast, Demand, 2034</a>  <font color="#6f6f6f">Straits Research</font>

Real-time search volume
200+25m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

2000+45m ago

selma blair

Selma Blair arrested for biting flight attendant, trying to open plane door

5000+55m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

500+55m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Search Results for "Checkpoint Inhibitor Refractor"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Case Report: Successful treatment of steroid-refractory immune checkpoint inhibitor associated myocarditis with tofacitinib
Frontiersworld

Case Report: Successful treatment of steroid-refractory immune checkpoint inhibitor associated myocarditis with tofacitinib

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPMnkzd2NXMTkteTE1SFZ3MmZ0dzVDWXh5TUpLSWJXMVE2REVDemY0clVvSDFabDZIeWU0aHIzZUtTRUVSeHlmaUNvNU8wdDZuNFdBQkdOT3VKdG5ZVlRzOE04X2hmcnFNOVJQMWhBTEMzVGhxNVNEcW5ydXNUVVdXQzJZQWJVbjRZZm4tS3Utel9rUQ?oc=5" target="_blank">Case Report: Successful treatment of steroid-refractory immune checkpoint inhibitor associated myocarditis with tofacitinib</a>  <font color="#6f6f6f">Frontiers</font>

Cytomegalovirus (CMV) Co-infection in Treatment-Refractory Immune Checkpoint Inhibitor-Associated Colitis: A Case Report
Cureusworld

Cytomegalovirus (CMV) Co-infection in Treatment-Refractory Immune Checkpoint Inhibitor-Associated Colitis: A Case Report

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxOZ1FVNzJaOHlKWUpZVnFiZElNSndSMG1ZVkhEdFliWDFCb1VfeEhkcUU4bEpBZlhVQlUtZXY4b09nVGJKa3VOel9BXzZJVk52Y0k1ZnB6TmZfdXIxNXFKRVI1Z1JrYlg5TmQ5akdOUzFMbTZvWUx0LW91WFA0Z0wxcEc0LWxfcEVHR0pqQ0s2TUhEcDVTckhlV0RvQ3hHOVdZWGpodEsyNHNLRWYyMnpud0RFNVVjTUZhUVljS2ZWTmRaV0hrT1hUWU1tUE5wbVFOVEZFeVlYYXRwR1NNNGpqcUJjcmNWcVlDMzZwUg?oc=5" target="_blank">Cytomegalovirus (CMV) Co-infection in Treatment-Refractory Immune Checkpoint Inhibitor-Associated Colitis: A Case Report</a>  <font color="#6f6f6f">Cureus</font>

Checkpoint Inhibitor Refractory Cancer Market Outlook is Predicted to Improve by 2036, Biopharma Companies Advance Novel Immuno-Oncology Candidates | DelveInsight
PR Newswiremarkets

Checkpoint Inhibitor Refractory Cancer Market Outlook is Predicted to Improve by 2036, Biopharma Companies Advance Novel Immuno-Oncology Candidates | DelveInsight

<a href="https://news.google.com/rss/articles/CBMivAJBVV95cUxPa3VMT2dxWHFhT2hKSFpES1FOanA2TUd3dnZETTJLbFI1dHdtSlJ4SFNWazhTZ3U3NFJ0ZHBTNHh0RFJZbTc3aURpaFlqdWJLR1NGQ05SMU1hQndueVB4eFBrTmVpc0FVVWF3LWZuRVBraExCWTNvOGlvYUFWNTFHZE5jQmNSd185X183UWtVSWNaMnVRbE13WjZFUHZFWXVxNnZFUmRtYi1GWUUzSGpHUWJVRkZ2THBQZDJzZkxoaGFWUWNLVkx3Qkl3XzhnQTloZkxHaVlZemk3WF9ENWNKcHZyYV9sR3F4THFPWnluWmszYnNiSGM2VFNZc3preG5OZGxXRWJIaEc4RXVHUlE4YnJTLXNjX1BjY2lmMzNwWG5WMkNGMld4Rzd4Z2dXTmdoUXpRVGVqa3N6dHRC?oc=5" target="_blank">Checkpoint Inhibitor Refractory Cancer Market Outlook is Predicted to Improve by 2036, Biopharma Companies Advance Novel Immuno-Oncology Candidates | DelveInsight</a>  <font color="#6f6f6f">PR Newswire</font>

Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma
CancerNetworkgeneral

Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzhjZGtFV05Ec0lrQ3JKOEFBUTZLZUZRLXFfRk0zNm8xVVhKS1NSUTVpMnpianFWZzJuanJWeTVCaFJxck9YRXRFMTJlQVNFMFBwYU5kY3lVYkVfT2RWMUMwWGg2TTdxOTFxWXQ3bWhucXAtQ2hpMHJaZTFsUzlRWE5UMDI0MHhYMjRPYjNMYzN1bWRhd0lXOUVlQW9IWDA2Wm8w?oc=5" target="_blank">Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma</a>  <font color="#6f6f6f">CancerNetwork</font>

How to Treat Immune Checkpoint Inhibitor–Refractory Renal Cell Carcinoma: Current Evidence and Remaining Questions
ASCO Daily Newstech

How to Treat Immune Checkpoint Inhibitor–Refractory Renal Cell Carcinoma: Current Evidence and Remaining Questions

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNemkwTVFPb0twRUU3bXNlX0pUeDByQTB5OHRIZ0laZFYxaU9VOU9zY3pKZlhwNVo5bGFwT181UXA3VnRQT09fa3RCZy1CTUJRa25SYjliNVR2czJ6UUNlQTdpYm9JTHh4bE1ycFFJVWw5cENrNndLZ3otMjJWRlJ3aVVTQnN3WkhlUW1RRGZJT1NCNGl3ay03d2J6WTNocEJKY2JCRlFSR3BPY2swZFlEWGdDTDB6TkVZMjNTdw?oc=5" target="_blank">How to Treat Immune Checkpoint Inhibitor–Refractory Renal Cell Carcinoma: Current Evidence and Remaining Questions</a>  <font color="#6f6f6f">ASCO Daily News</font>

Case Report: Successful treatment of steroid-refractory severe immunotherapy-induced pneumonitis with equine antithymocyte globulin
Frontiersworld

Case Report: Successful treatment of steroid-refractory severe immunotherapy-induced pneumonitis with equine antithymocyte globulin

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPel9WOXVLekxTOUlIRjh1WUlHYTFIYVM3czFhaUFiTmlyN2dsU0YzdlNYNDlMY3BhRGQ0bmROQ09RdkhBY0FzXzBYcWRzMFlkakhzUWVBcmxYVnVQVVJWYS1FMzNZalZURjJWc0Vud2ZHQUxCLUdBNWh5UzhUanBoR2xENGZTZE1RV1NkcDRn?oc=5" target="_blank">Case Report: Successful treatment of steroid-refractory severe immunotherapy-induced pneumonitis with equine antithymocyte globulin</a>  <font color="#6f6f6f">Frontiers</font>

Checkpoint Inhibitor Refractory Cancer Market | Global Market Analysis Report - 2035
Future Market Insightsmarkets

Checkpoint Inhibitor Refractory Cancer Market | Global Market Analysis Report - 2035

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQNVlnRTlpWnFta3E3dHMzSUxVQXlsV29XOEdtYVcyQlVfRUx2dzc5ZTJaZk55MlJOTktHcVNnSVVHSjE4a3I3MV9YeWEyTk9nR0wxZ1Zhd2VFVU5MX3J4cllrdDBuWjRjMkFlTExmOU1kN0NYZTRsQTE3RU9aQlBQQmYwdEtld3FKbVNwSnd2bERZaENT?oc=5" target="_blank">Checkpoint Inhibitor Refractory Cancer Market | Global Market Analysis Report - 2035</a>  <font color="#6f6f6f">Future Market Insights</font>

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Natureworld

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9QZ09CNnFSYzdBcENwYlQ4Zmw4emFZN0lkNC1fWExNNnlRbDl1cTk5QlVLYkNCMjQyR0VQZURZSmQ4Tnl0M0hIcHdkelNtempKenJLVDhBMzZ0SkFSNFE?oc=5" target="_blank">Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis</a>  <font color="#6f6f6f">Nature</font>

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis
Science | AAASworld

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE13Y2FHblB1Wk5xdldURnZNeWxFazdmc2RfYkZZY0tVS3dFdmZrd0VsOWt2WHEwSVhLTmw2N0l3czlJcnBEVXhHOGNMS1BkckZpX3I5MGNWZkRRMzc1QS1iWFRCMVJMZzA?oc=5" target="_blank">Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis</a>  <font color="#6f6f6f">Science | AAAS</font>

Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors
The New England Journal of Medicineworld

Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TbERDekQ2X1lQa2UxblY5R1pqQmVsNkFOc0tmZEtzVXdHNUJ0VTFNS1VYZjFvNEpacWh3SXpqcDNUVFF5ODF4QmxVWGU4NUo4eW1NOFlIQk9WUWJjcDRF?oc=5" target="_blank">Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Teaching Video NeuroImage: Response to IVIg in a Patient With Steroid-Refractory Immune Checkpoint Inhibitor–Related Ocular Myopathy
Neurology® Journalsworld

Teaching Video NeuroImage: Response to IVIg in a Patient With Steroid-Refractory Immune Checkpoint Inhibitor–Related Ocular Myopathy

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE02b3BNaXFSbEVObDBXNVNFSEhEZVNXTXh2cm9fTUY5WVFkTjYxVWFfS0o3ZFNBeFYtNWVXRjVFelFGMk9ubENQZXNFTENFTzJCU3JPRGRtdTA4dDM2LXEzMWtKZXlqYzktd3c?oc=5" target="_blank">Teaching Video NeuroImage: Response to IVIg in a Patient With Steroid-Refractory Immune Checkpoint Inhibitor–Related Ocular Myopathy</a>  <font color="#6f6f6f">Neurology® Journals</font>

CAN-2409 Shows Strong OS Outcomes in ICI-Refractory NSCLC
Targeted Oncologygeneral

CAN-2409 Shows Strong OS Outcomes in ICI-Refractory NSCLC

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQNjQxd1BGQ2pMZU9OYk04ZGlHeU04akk3Ympaa0dYeW1ERVh5QTdzUzBkRVZCdWpsVFVVOWNaV3RsNVRQQjU0X3cwUzJSa1k2Y2JXX2ZLYXk5TEFNcHBJbmN1UTItMDZja0lBVHNlSnpWQk04cUVUVnc4RlEySG1Cd0JiaXAxN0RTQ3VIMkdZTWpaT09K?oc=5" target="_blank">CAN-2409 Shows Strong OS Outcomes in ICI-Refractory NSCLC</a>  <font color="#6f6f6f">Targeted Oncology</font>

Corticosteroid-Refractory Bullous Pemphigoid Due to Immune Checkpoint Inhibitors: A Telemedicine Challenge
Cureusworld

Corticosteroid-Refractory Bullous Pemphigoid Due to Immune Checkpoint Inhibitors: A Telemedicine Challenge

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNU1haNnlVN0Fielp5WnYwejVBT2xwVEtmNjhjN1JsaW1saVNVWi0yZkROd21uV1RHWjc2TWUzMWxvLWRIcWk5RVFRbmxhUGRmbGFxb3B3RmxWMm1vZHFjUnEzR3RVMkZQemRqMl9iSTJCMkZCMGJVdXd4NWFIN0RTbk5kdTI0VzZnTXNLbFJ3bGpfWmUxU3BuQXVyRU9ieDd4ckVQc2puSDUwc29xOElrbGEwME9GMDJVSG1hd1FlUkNQeWJocWpPNzlBTHo2bXFnVGtWcnlPTmhqMmhn?oc=5" target="_blank">Corticosteroid-Refractory Bullous Pemphigoid Due to Immune Checkpoint Inhibitors: A Telemedicine Challenge</a>  <font color="#6f6f6f">Cureus</font>

How Will Emerging Treatments for PD-1–Refractory Melanoma Shape the Delivery of Care?
ASCO Daily Newsgeneral

How Will Emerging Treatments for PD-1–Refractory Melanoma Shape the Delivery of Care?

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNZlJDeWRiLWFRTnRrMndzaHVRaFdTdzZNVDh4M1NpZXU2b2dQMnRvdTZTNHNBN21Uek1taUVFMGdOMWwxSlJKOTFPeDd4WEF6TEl5M2pjUzlwcE5ERHVPazY4d1hBTVllc0YzUUMzRWZYQzJSNWwxejdRZXR3OTdITnBVeGxaQ1NXUkJLZ25JQUdBWVhDMHo0LWZ4dlBaQ00?oc=5" target="_blank">How Will Emerging Treatments for PD-1–Refractory Melanoma Shape the Delivery of Care?</a>  <font color="#6f6f6f">ASCO Daily News</font>

Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects
Frontiersworld

Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOS2JHWm9wWktLeHVIR2NHZm8yVjhhYTZWTTM2LXpZRXBYMVM2ODJjMnRjM0JHbk9mbHpham00bFdIUjU1M3RlejkxcXh2TmxJYUJ2RzdTRTEyRjB4czVUUm80SlBib2EtdU5oMmpCS0VVZWtvejE3OVIzOVZLbm9oVktoSVJqOU1ZUW96cldB?oc=5" target="_blank">Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects</a>  <font color="#6f6f6f">Frontiers</font>

Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
Frontiersworld

Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPbW1Ib3VyWC1nV3lzQmdBVU53ejNmYjdvMjFuckF6WGEwY2NqU2pielFYRS12NFNpdE1udnF1MEpmV1BQVHlWZjBGWWNyS1VLTGJqd2FSbHhZRE5FMVczdnNMWXJsMUItRTBuVUtIZVZhQmg5a0h1SkE3eTQxZVhIRzhyZm5fdjB3SF9N?oc=5" target="_blank">Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin</a>  <font color="#6f6f6f">Frontiers</font>

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
Frontiersworld

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQZFR2Nzkzbnk3VkdmQ0xMRGc0d2xCbjJLZF92VWtfaGI5d21YNzRnRGxYQ0xvZHdvNndKbjYtTEZxZE1IOEVabkZJQUc5d2huQWpLMGlYb3NtbHA2SU1Pdm1JZktSTzNxTUdzeGxmQVRhakxlSmgwTUdHdzYtZTBrbDdIcnNzOEJFVXlWOHNDNlZYdw?oc=5" target="_blank">A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy</a>  <font color="#6f6f6f">Frontiers</font>

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma
Frontiersgeneral

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQUTJHdG1RbXk1ZkFKQ2ZvQWt6WUdHdDlkSVo3TmpqYjlJdm9jRnI4TGkwR1ozeHl1ZW5HZXl0Y1hJY2pvRzZoME5oNFFpUTRKZjVCeDR3dVpQZXdFTzV6WHl4UjJkZEduQ09GUXA5bkVlT2hDOTZMZVl0SmI0TDgzS2dzNEtia0hEVG9uNGln?oc=5" target="_blank">The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma</a>  <font color="#6f6f6f">Frontiers</font>

Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management
Frontiersworld

Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOelNQRjlrLW9NR3NpM1lUTTh6d24yUkFkVDRtOW5XSTR4YXI0WDVsY2p1VDJKOVNENHJrUVEtanhNQ1ZvNFNONTdBZE8wRzRhbDh1SjdUa3RCTEFmcUF4d0lkbHFNRlhPa3ZfUmk3empPLVdKRF9MU1UwbExNYWRJaDJETlp5QzQ3cHZkNlZFTW5Mdw?oc=5" target="_blank">Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management</a>  <font color="#6f6f6f">Frontiers</font>

ASCO25: Strand touts early synthetic mRNA data in checkpoint inhibitor-refractory tumours
FirstWord Pharmageneral

ASCO25: Strand touts early synthetic mRNA data in checkpoint inhibitor-refractory tumours

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1zSThXcVpfNFpJVGJiQ3lNYjk1RzBUU2ZFR1ZpMk5jbWVKdFJqMWZnVGwwVzQtXzI3ZHFxVFlQcGt6QzZCaEN0M1hkdWlFRzd0SFM0?oc=5" target="_blank">ASCO25: Strand touts early synthetic mRNA data in checkpoint inhibitor-refractory tumours</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Docetaxel Remains Unbeaten in Immunotherapy-Refractory NSCLC
OncLivetech

Docetaxel Remains Unbeaten in Immunotherapy-Refractory NSCLC

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNTDQtblVEQlBqYUJ4SlVjSnBaR1g3bGFmX2dBNXNacUNIT0pBSFdrSVJBdEtGT3QwYnBBX0lVR2N1SFhoNlZLSUJjanJmc0hnQ0dVZDNDNWlPYk1NZzhwMmxEakQ1bTRmUUVmUHVPNmFuNU1HMU9VMFpLVjhYQVAycGZsR1pFWlZ4azZmc2dFOWxQUDg?oc=5" target="_blank">Docetaxel Remains Unbeaten in Immunotherapy-Refractory NSCLC</a>  <font color="#6f6f6f">OncLive</font>

Immune Checkpoint Inhibitor–Induced Colitis: Can We Balance Treatment Toxicities Against Effective Care?
ASCO Daily Newstech

Immune Checkpoint Inhibitor–Induced Colitis: Can We Balance Treatment Toxicities Against Effective Care?

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPS2lHVDItdWlRdlgxMmhBX0lmczBsVEtDSFdrQU9BWk52R3JzTWhqbzNZTmRYVnNoc3VHR3pCVzBaQjdGdzRmMzloc2F6Qm8tMUhaTUdvYlN4bFdZX2lHUlFDa2VYZ1N4MWZfQ0tMRmVHRXk0WHhhaEhhUlZJLW1HS0lGMDFMUWQzejIxR1NVcHVYT0VhT3M2ZGxVWGNma1JFSHR5QjlEeTREc2hiS2RldWVzajlraTFFbXNsbTRB?oc=5" target="_blank">Immune Checkpoint Inhibitor–Induced Colitis: Can We Balance Treatment Toxicities Against Effective Care?</a>  <font color="#6f6f6f">ASCO Daily News</font>

Lifileucel Paves the Way for Evolving Treatment Approaches After PD-1 Inhibition in Advanced Melanoma
OncLivegeneral

Lifileucel Paves the Way for Evolving Treatment Approaches After PD-1 Inhibition in Advanced Melanoma

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOeTllRC1jWHlRSTduV3JQRlhtNkYzNGJja1ZtYzJnb2RWczhTVWFIVkhDUVhQb2l4T05oNmQyR0RqUUFhRktFTEFGNkp1Sk1pU09ZNVJuX0Y5Mm9hVDk0d240Y3pWRXlXSkNaUk9jVnFvRUJrM1p4NjBJZ1JhVUpjcjhDd2RrNHFQS21wRVp3UnFoS0hoaTdPX3NoZjd3QlpTMHlaVDdnUTVVcEI3WEpNTWlqRXkzNHF5eEVHTjBnckIyUjFaMDJEZThB?oc=5" target="_blank">Lifileucel Paves the Way for Evolving Treatment Approaches After PD-1 Inhibition in Advanced Melanoma</a>  <font color="#6f6f6f">OncLive</font>

Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review
Frontiersworld

Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPb1BYT1hHaW5Xd1Jyd1JVcjVJdHkwNFVjRjNqaXJkc2tMY1lsemtxWHFTZXNTbWEyb2dhS09Vdzd4c3Z3czJ3d1NhdE1MY1lnRWJLek9saUdWaFF2SWd6eXgyQUZjbU1seFFnSWlRX1BTNV9FR0k2d1VHeV95dnlXRVZpYUlkVnR4eVNyUlNoci0?oc=5" target="_blank">Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review</a>  <font color="#6f6f6f">Frontiers</font>

Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
PR Newswireworld

Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers

<a href="https://news.google.com/rss/articles/CBMi2gJBVV95cUxNN2VWUFdMcER5M2lqY2ZMek9UbU5XVkh4bzhQdWt4SExyWjE4WkRkci16dlJ3OUpORjZ3bDFPaFBLOEljZndqM2htYXIzYVdIM0xzcFBsMFV2Wjc0QmxSLWJjUTRjMkxEZXhfX1RtOUVUc3RpRkFLZXVKbnV2M2E2a3NoYWN4YVN5VGpmQVRMTmRRcmdpU1g2OXJaU2ZiOThhOEoyMXlkcURObDNVWXM5M2lHd09BTXRFRlhRRDROQW92LU1MUWlfWjJDLUZpOERKSTZtQnRwVlE5aUI2QXA1OEU1czFyOVlVX0ltRlR2QjRkak9pUWNCZVhZRjcyWjdhUUJqUHFOTENDS2RpQkZfQzdKQlR0RU1Sdk10czVXT01iRng2bzZzbUlfNjc3Rnp4cmZvUXMwbXFCVTdxTVE4YUExYU9iRGYxTDhXU2tDUjdNaEp2SF9pRDJ3?oc=5" target="_blank">Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers</a>  <font color="#6f6f6f">PR Newswire</font>

Considering Lifileucel for PD-1–Refractory Advanced Melanoma
Targeted Oncologygeneral

Considering Lifileucel for PD-1–Refractory Advanced Melanoma

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQRHduU2x0WWUwaWFVMUxXd3VoVVROdjN4VUZvX2F0dU1ETlNjRTZRaUM0VGZDb0VuZEtfUkc1NEZaZGY4Ul9mV2pfUzdyMjFReFlXbXNPQkJyaFpCUjZEOVpPbm9faW5UMTBhY2VOdGVRVjd3eWdENzhrZ3VFRjZBVnoxM3RNaFQ0ckwzX0g5NkNBVHowSjgtZg?oc=5" target="_blank">Considering Lifileucel for PD-1–Refractory Advanced Melanoma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Q&A: What Tudriqev's Approval Means for PD-1-Refractory Melanoma
Dermatology Timesgeneral

Q&A: What Tudriqev's Approval Means for PD-1-Refractory Melanoma

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOLXUxNUdRVENZNjg2elljYnRMczdJcm45cmEzbHkwc0NxZnctOVpLUDNsN0R0aGZwOVhDbjN4blBvZ0VvS2l1YUwtNHE1SXBTa3RSeUJxclZRN2dlSFNBbmdCOWhaT0JPZGlpVWp0TXJrU1Nrc3ZGZkExbWN6Vm1zSGhjU2FfRTBYel9KbldiUmZ5MDVtLUZ4aHY5LUhXZw?oc=5" target="_blank">Q&A: What Tudriqev's Approval Means for PD-1-Refractory Melanoma</a>  <font color="#6f6f6f">Dermatology Times</font>

Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial
Natureworld

Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Lc3JHcFN1c0Jodmx2RHBfSWctVlNodG1Db3I3ZkR2bjc5RkRYVHFWa1BXX1d3aldhR2xVSjQ3RkI0SGpMeTJVYWstLWN6djJqTGFZa0pIZnpUdUZLdHN3?oc=5" target="_blank">Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial</a>  <font color="#6f6f6f">Nature</font>

Salvage Checkpoint Inhibitors Reduce Peri-ASCT Progression in R/R Hodgkin Lymphoma
OncLivegeneral

Salvage Checkpoint Inhibitors Reduce Peri-ASCT Progression in R/R Hodgkin Lymphoma

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQaEhmYlpob2F0X3RXeXg4TS02M1BMQldtZWtuTkZtNlp4bjJqOUJ1WG40MTZUd2VSMzB4ZnBXaTdiU1JzLU5fdElsaWVGM3NoSG5hUmhrRF84RFUzV1hpaDRiOV9OTUJXYWRIdTA0d2pwb1BLemIyWExmZDAyTWpYRG1kSzcxVHMwVS1iN3NyOHVFWTNDaEJDbERvOTZtWkFhMmFmYkdQblh3bE9JclFpbA?oc=5" target="_blank">Salvage Checkpoint Inhibitors Reduce Peri-ASCT Progression in R/R Hodgkin Lymphoma</a>  <font color="#6f6f6f">OncLive</font>

"Checkpoint Inhibitor Refractor" — Live Google News Trends & Headlines